Abstract
The influence of glucagon and aprotinin ('Trasylol') on the death-rate of acute pancreatitis has been studied in a randomised double-blind multicentre trial. The death-rate in 257 patients was 11%. In the doses used neither drug was found to diminish the risk of death.
Publication types
-
Clinical Trial
-
Comparative Study
-
Randomized Controlled Trial
MeSH terms
-
Acute Disease
-
Adult
-
Age Factors
-
Aged
-
Aprotinin / administration & dosage
-
Aprotinin / therapeutic use*
-
Clinical Trials as Topic
-
Drug Administration Schedule
-
Drug Evaluation
-
Drug Therapy, Combination
-
Female
-
Glucagon / administration & dosage
-
Glucagon / therapeutic use*
-
Humans
-
Infusions, Parenteral
-
Male
-
Middle Aged
-
Pancreatitis / drug therapy
-
Pancreatitis / etiology
-
Pancreatitis / mortality*
-
Placebos
-
Sex Ratio
Substances
-
Placebos
-
Glucagon
-
Aprotinin